glp-1 drugs pharmaceutical companies partnerships 2025 Market Size to Hit USD 212.73 Billion by 2035 GLP-1 Market Size, Share |
Description
We only needed approval from the institutional review board' (Nair)
Highlights of Prescribing Information: Wegovy (semaglutide) tablets, for oral use
The Reward System: GLP-1 also modulates the brains reward pathways, particularly areas rich in dopamine receptors
However, GLP-1s can come with challenges, including gastrointestinal side effects, risk of micronutrient deficiencies, muscle and bone loss, poor long-term follow through with weight regain if stopped, and high costs
The GLP-1 supplement category barely existed before 2023
